Galectin Therapeutics Cut to Neutral From Buy by HC Wainwright & Co.

Dow JonesDec 28, 2024 00:52 · Ratings

Galectin Therapeutics Analyst Ratings

BenzingaDec 28, 2024 00:40 · Ratings

H.C. Wainwright Downgrades Galectin Therapeutics(GALT.US) to Hold Rating

Futu NewsDec 28, 2024 00:32 · Ratings

12 Health Care Stocks Moving In Friday's Pre-Market Session

BenzingaDec 21, 2024 05:06

Catalyst Watch: Labor Pains for Amazon & Starbucks, Nasdaq Call-up for MicroStrategy and Pony AI Ratings

Seeking AlphaDec 21, 2024 04:00

Galectin Therapeutics Shares Drop 54% After Treatment Misses Trial Endpoint

WSJDec 21, 2024 03:44